$250 | Single User
$500 | Site License
$750 | Global License

AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

Published by Global Data: 16 Oct 2018 | 225390 | In Stock

Introduction

Summary

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virology and metabolic therapy areas. The company also offers medicines for neurological disorders and other serious health conditions. AbbVie discovers and develops novel medicines based on protein-based and targeted drug delivery technologies. The company its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses across the world. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

    AbbVie Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

    AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

    AbbVie Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

    AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

    AbbVie Inc, Medical Equipment, Deal Details 11

    Venture Financing 11

    Stem CentRx Raises more than USD100 Million in Financing Round 11

    Partnerships 12

    AbbVie Enters into Licensing Agreement with Cerveau Technologies 12

    AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 13

    Enterome Enters into Co-Development Agreement with AbbVie 14

    Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 15

    Debt Offering 16

    AbbVie Raises USD1.75 Billion in Public Offering of 4.875% Notes Due 2048 16

    AbbVie Raises USD1.25 Billion in Public Offering of 3.375% Notes Due 2021 18

    AbbVie Raises USD1.75 Billion in Public Offering of 4.25% Notes Due 2028 20

    AbbVie Raises USD1.25 Billion in Public Offering of 3.75% Notes Due 2023 22

    AbbVie Raises USD1.53 Billion in Public Offering of 1.38% Notes Due 2024 24

    AbbVie Raises USD1.48 Billion in Public Offering of 0.38% Notes Due 2019 25

    AbbVie Raises USD795.6 Million in Public Offering of 2.13% Notes Due 2028 26

    AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 27

    AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 29

    AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 31

    AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 33

    AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 35

    AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 37

    AbbVie Raises USD3.1 Billion in Public Offering of 2.9% Notes Due 2022 39

    AbbVie Raises USD2.6 Billion in Public Offering of 4.4% Notes Due 2042 40

    AbbVie Raises USD1 Billion in Public Offering of 2% Notes Due 2018 41

    AbbVie Raises USD4 Billion in Public Offering of 1.75% Notes Due 2017 42

    AbbVie Inc - Key Competitors 43

    AbbVie Inc - Key Employees 44

    AbbVie Inc - Locations And Subsidiaries 45

    Head Office 45

    Other Locations & Subsidiaries 45

    Recent Developments 54

    Strategy And Business Planning 54

    Jan 09, 2017: AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance 54

    Financial Announcements 55

    Jul 27, 2018: AbbVie Reports Second-Quarter 2018 Financial Results 55

    Apr 26, 2018: AbbVie Reports First-Quarter 2018 Financial Results 58

    Jan 26, 2018: AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results 60

    Oct 27, 2017: AbbVie Reports Third-Quarter 2017 Financial Results 62

    Jul 28, 2017: AbbVie Reports Second-Quarter 2017 Financial Results 64

    Apr 27, 2017: AbbVie Reports First-Quarter 2017 Financial Results 66

    Jan 27, 2017: AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results 68

    Corporate Communications 70

    Aug 20, 2018: AbbVie announces 100 million donation to Ronald McDonald House Charities to support hospitalized children and their families 70

    May 22, 2018: AbbVie Donates 0 Million to Strengthen Access to Healthcare, Housing for Hurricane-Ravaged Puerto Rico 71

    Sep 07, 2017: AbbVie Leads Biotechnology Industry on Dow Jones Sustainability Index for Second Consecutive Year 73

    Legal and Regulatory 74

    Jul 31, 2017: AbbVie Announces Delisting from Euronext Paris 74

    Product News 75

    May 17, 2017: AbbVie to Present Latest Clinical Study Results in Hematology and Solid Tumor Research at the 53rd American Society of Clinical Oncology Annual Meeting 75

    Appendix 77

    Methodology 77

    About GlobalData 77

    Contact Us 77

    Disclaimer 77

List Of Tables
in AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

List of Tables

AbbVie Inc, Medical Equipment, Key Facts, 2017 2

AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

AbbVie Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

AbbVie Inc, Deals By Market, 2012 to YTD 2018 9

AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Stem CentRx Raises more than USD100 Million in Financing Round 11

AbbVie Enters into Licensing Agreement with Cerveau Technologies 12

AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 13

Enterome Enters into Co-Development Agreement with AbbVie 14

Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 15

AbbVie Raises USD1.75 Billion in Public Offering of 4.875% Notes Due 2048 16

AbbVie Raises USD1.25 Billion in Public Offering of 3.375% Notes Due 2021 18

AbbVie Raises USD1.75 Billion in Public Offering of 4.25% Notes Due 2028 20

AbbVie Raises USD1.25 Billion in Public Offering of 3.75% Notes Due 2023 22

AbbVie Raises USD1.53 Billion in Public Offering of 1.38% Notes Due 2024 24

AbbVie Raises USD1.48 Billion in Public Offering of 0.38% Notes Due 2019 25

AbbVie Raises USD795.6 Million in Public Offering of 2.13% Notes Due 2028 26

AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 27

AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 29

AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 31

AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 33

AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 35

AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 37

AbbVie Raises USD3.1 Billion in Public Offering of 2.9% Notes Due 2022 39

AbbVie Raises USD2.6 Billion in Public Offering of 4.4% Notes Due 2042 40

AbbVie Raises USD1 Billion in Public Offering of 2% Notes Due 2018 41

AbbVie Raises USD4 Billion in Public Offering of 1.75% Notes Due 2017 42

AbbVie Inc, Key Competitors 43

AbbVie Inc, Key Employees 44

AbbVie Inc, Subsidiaries 45

List Of Figures, Charts and Diagrams
in AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

List of Figures

AbbVie Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

AbbVie Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

AbbVie Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

225390 | GDME430057D

Number of Pages

77

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Abbvie Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
20 Jul 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
14 Apr 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
05 Apr 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic...
22 Mar 2016 by Global Data USD $300 More Info
AbbVie Inc. (ABBV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
03 Mar 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
24 Feb 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic...
15 Dec 2015 by Global Data USD $300 More Info
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic...
01 Dec 2015 by Global Data USD $300 More Info
Physician Views: And then there were two – will AbbVie's 3-DA regimen prove a compelling competitor to Gilead's Harvoni?
Scope Later this month, the FDA is expected to approve AbbVie's oral '3-DA' product - comprising Vie...
11 Dec 2014 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data